Oncology Medical Science Liaison – Italy/Germany

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics seeks an experienced Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. This field-based role engages investigators and treatment centres, driving trial awareness and high-quality scientific exchange within compliance.The candidate will work independently in a distributed...

Quetzal Therapeutics seeks an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. Non si lasci sfuggire questa opportunità: si candidi rapidamente se la sua esperienza e le sue competenze corrispondono a quanto descritto di seguito. The role emphasizes

Quetzal Therapeutics seeks an experienced Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. Il suo CV è pronto? Se sì, e se è convinto/a che questo sia il ruolo giusto per lei, si candidi il prima possibile. This field-based role engages investigators and treatment

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company's lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company's lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is...

An exciting oncology launch opportunity!Sia tra i primi a candidarsi: legga la panoramica completa del ruolo qui sotto, quindi invii la sua candidatura per essere preso/a in considerazione.Senior Medical Science Liaison Manager (F/M/X) ItalyOur client is a pioneering oncology company developing innovative targeted therapies for patients with RAS-driven...

subrosa Health & Capital group seeks a Senior Medical Science Liaison Manager (F/M/X) for Italy to support an oncology launch.Scorra verso il basso per trovare i dettagli completi dell'offerta, inclusa l'esperienza richiesta e le mansioni associate.The role focuses on building scientific relationships with KOLs, HCPs and study sites, and preparing the...